niacinamide has been researched along with inosine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (64.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (10.71) | 29.6817 |
| 2010's | 3 (10.71) | 24.3611 |
| 2020's | 4 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ferraris, DV | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Bennett, LL; Nelson, JA; Rose, LM | 1 |
| Berg, P; Krowke, R; Merker, HJ | 1 |
| Longman, DA; Slater, P | 1 |
| Costa, E; Guidotti, A | 1 |
| Akhundov, RA; Rozhanets, VV; Val'dman, AV; Voronina, TA | 1 |
| Anderson, BM; Imai, T | 1 |
| Bold, JM; Gardner, CR; Walker, RJ | 1 |
| Akhundov, RA; Valdman, AV; Voronina, TA | 1 |
| Foti, V; Piazza, E; Sindoni, G; Stornello, C | 1 |
| Voronina, TA | 2 |
| Akhundov, RA; Voronina, TA | 1 |
| Akhundov, RA; Andronati, SA; Chepelev, VM; Voronina, TA | 1 |
| Abramets, II; Dolzhenko, AT; Komissarov, IV | 1 |
| Lapin, IP | 3 |
| Baue, AE; Chaudry, IH | 1 |
| Bernard, EA; De Souza, LF; Gelain, DP; Jardim, FR; Moreira, JC; Ribeiro, GR; Zim, M | 1 |
| Bracht, A; Bracht, F; Broetto-Biazon, AC; Constantin, J; de Sá-Nakanishi, AB; Kelmer-Bracht, AM; Lopez, CH | 1 |
| Bracht, A; Bracht, F; Bracht, L; Broetto-Biazon, AC; Kelmer-Bracht, AM | 1 |
| Abdelkader, NF; Elbaset, MA; Ibrahim, SM; Moustafa, PE | 1 |
| Blanco, LP; Bley, M; Brenner, C; Hassanzadeh, S; Huffstutler, RD; Kaplan, MJ; Lin, A; Meadows, AM; Pirooznia, M; Sack, MN; Schmidt, MS; Shing, V; Singh, K; Tian, R; Wu, J; Wu, K | 1 |
| Kharitonova, T; Orlova, NS; Puzyreva, VP; Shvarts, YG; Strokov, IA; Verbovoy, AF | 1 |
| Antonova, EA; Belikova, TN; Kovalenko, AL; Morozov, VG; Popova, VB; Rafalskiy, VV; Stel'makh, VV; Uspenskiy, YP | 1 |
5 review(s) available for niacinamide and inosine
| Article | Year |
|---|---|
Evolution of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors. From concept to clinic.
Topics: Animals; Antineoplastic Agents; Binding Sites; Drug Discovery; Drug Industry; Enzyme Inhibitors; History, 20th Century; History, 21st Century; Humans; Ischemia; Niacinamide; Poly(ADP-ribose) Polymerase Inhibitors; Research | 2010 |
Endogenous ligands for benzodiazepine recognition sites.
Topics: Animals; Benzodiazepines; Benzodiazepinones; Binding Sites; Binding, Competitive; Brain; Caffeine; Carrier Proteins; Chlorides; Conflict, Psychological; Diazepam Binding Inhibitor; Flumazenil; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Humans; Hypoxanthine; Hypoxanthines; Inosine; Ion Channels; Membrane Proteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neuroglia; Neurons; Niacinamide; Organic Anion Transporters; Peptides; Phosphorylation; Protein Conformation; Protein Precursors; Receptors, GABA-A; Synaptic Membranes; Tissue Distribution; Trypsin | 1985 |
"Endogenous ligands" of benzodiazepine receptors, their structural analogs. Development of new psychotropic drugs.
Topics: Animals; Behavior, Animal; Benzodiazepines; Brain; Humans; In Vitro Techniques; Inosine; Niacinamide; Psychotropic Drugs; Receptors, GABA-A | 1985 |
[Benzodiazepines, receptor affinity, their endogenous ligands and the modeling of new psychotropic preparations].
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Carbolines; Carrier Proteins; Central Nervous System; Chemical Phenomena; Chemistry, Physical; GABA Plasma Membrane Transport Proteins; Inosine; Ligands; Membrane Proteins; Membrane Transport Proteins; Mice; Models, Chemical; Nerve Tissue Proteins; Niacinamide; Organic Anion Transporters; Rats; Receptors, GABA-A; Solubility; Structure-Activity Relationship | 1984 |
[Endogenous modulators of the sensitivity of the postsynaptic membranes of GABA-ergic brain synapses].
Topics: Animals; Anti-Anxiety Agents; Benzodiazepines; Brain; Carbolines; Cell Membrane; Convulsants; Harmine; Humans; Inosine; Ligands; Neurotransmitter Agents; Niacinamide; Rats; Receptors, GABA-A; Receptors, Neurotransmitter | 1984 |
2 trial(s) available for niacinamide and inosine
| Article | Year |
|---|---|
Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (C
Topics: Antioxidants; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Humans; Inosine; Male; Niacinamide; Riboflavin; Succinic Acid | 2022 |
[The results of phase III multicenter open randomized controlled study REM-Chol-III-16 in patients with intrahepatic cholestasis syndrome caused by chronic diffuse liver diseases].
Topics: Alkaline Phosphatase; Bilirubin; Cholestasis, Intrahepatic; gamma-Glutamyltransferase; Humans; Inosine; Meglumine; Methionine; Niacinamide; S-Adenosylmethionine; Succinic Acid; Transaminases | 2021 |
21 other study(ies) available for niacinamide and inosine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Cells, Cultured; Guanine Nucleotides; Guanosine Triphosphate; IMP Dehydrogenase; Inosine; Inosine Nucleotides; Leukemia L1210; Niacinamide; Ribonucleotides; Thiadiazoles; Uracil Nucleotides | 1976 |
Effects of cytosine arabinoside, 6-aminonicotinamide, and 6-mercaptopurine riboside on ectoderm and mesoderm of mouse limb buds.
Topics: 6-Aminonicotinamide; Animals; Cytarabine; DNA; Ectoderm; Embryo, Mammalian; Extremities; Female; Glucose; In Vitro Techniques; Inosine; Maternal-Fetal Exchange; Mesoderm; Mice; Niacinamide; Phosphates; Pregnancy; RNA; Teratogens; Thioinosine; Time Factors | 1977 |
Effects of diazepam and muscimol on GABA-mediated neurotransmission: interactions with inosine and nicotinamide.
Topics: Animals; Corpus Striatum; Diazepam; Drug Interactions; Female; gamma-Aminobutyric Acid; Globus Pallidus; Inosine; Muscimol; Niacinamide; Oxazoles; Rats; Synaptic Transmission; Time Factors | 1979 |
[Mechanism of the tranquilizing action of electron structural analogs of nicotinamide].
Topics: Animals; Benzodiazepinones; Bicuculline; Brain; Conflict, Psychological; Flumazenil; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Inosine; Male; Niacinamide; Radioligand Assay; Rats; Receptors, GABA-A; Serotonin; Synaptosomes; Tranquilizing Agents; Valproic Acid | 1986 |
Nicotinamide riboside phosphorylase from beef liver: purification and characterization.
Topics: Amino Acids; Animals; Cattle; Guanosine; Inosine; Kinetics; Liver; Molecular Weight; Niacinamide; Pentosyltransferases; Protein Conformation; Purine-Nucleoside Phosphorylase; Pyridinium Compounds; Substrate Specificity | 1987 |
Central effects of nicotinamide and inosine which are not mediated through benzodiazepine receptors.
Topics: Action Potentials; Animals; Benzodiazepinones; Bicuculline; Binding, Competitive; Brain; Chlordiazepoxide; Convulsants; Female; Flumazenil; Flunitrazepam; In Vitro Techniques; Inosine; Male; Membranes; Niacinamide; Purkinje Cells; Rats; Rats, Inbred Strains; Receptors, GABA-A; Social Behavior | 1985 |
[Clinico-therapeutic evaluation of a new drug combination with hepatotrophic effect].
Topics: Adenine; Adult; Child; Drug Combinations; Folic Acid; Hepatitis A; Humans; Hydroxocobalamin; Inosine; Liver Diseases; Methionine; Middle Aged; Niacinamide; Nucleosides; Riboflavin; Vitamin B 12 | 1972 |
[Cross tolerance when benzodiazepines are administered with other substances].
Topics: Animals; Anti-Anxiety Agents; Antipsychotic Agents; Benzodiazepines; Drug Interactions; Drug Tolerance; Ethanol; Inosine; Male; Mice; Muscimol; Niacinamide; Phenobarbital; Valproic Acid | 1981 |
[Nootropic and anxiolytic properties of endogenous ligands of benzodiazepine receptors and their structural analogs].
Topics: Amnesia; Amnesia, Retrograde; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Conflict, Psychological; Humans; Hypoxia; Inosine; Ligands; Male; Mice; Niacinamide; Rats; Receptors, Cell Surface; Receptors, GABA-A | 1984 |
Dissimilar effects of nicotinamide and inosine, putative endogenous ligands of the benzodiazepine receptors, on pentylenetetrazol seizures in four strains of mice.
Topics: Animals; Anticonvulsants; Injections, Intraperitoneal; Injections, Intraventricular; Inosine; Ligands; Male; Mice; Niacinamide; Pentylenetetrazole; Receptors, Drug; Receptors, GABA-A; Seizures | 1980 |
Nicotinamide, inosine and hypoxanthine, putative endogenous ligands of the benzodiazepine receptor, opposite to diazepam are much more effective against kynurenine-induced seizures than against pentylenetetrazol-induced seizures.
Topics: Animals; Anticonvulsants; Binding, Competitive; Diazepam; Hypoxanthines; Inosine; Kynurenine; Ligands; Male; Mice; Mice, Inbred Strains; Niacinamide; Pentylenetetrazole; Receptors, Drug; Receptors, GABA-A; Seizures | 1981 |
Non-specific, non-selective and mild increase in the latency of pentylenetetrazol seizures produced by large doses of the putative endogenous ligands of the benzodiazepine receptor.
Topics: Animals; Hypoxanthines; Injections, Intraperitoneal; Injections, Intraventricular; Inosine; Ligands; Male; Mice; Mice, Inbred BALB C; Niacinamide; Pentylenetetrazole; Receptors, Drug; Receptors, GABA-A; Seizures; Time Factors | 1981 |
The use of substrates and energy in the treatment of shock.
Topics: Adenosine; Adenosine Triphosphate; Allopurinol; Animals; Cyclic AMP; Dogs; Glucose; Humans; Inosine; Insulin; Niacinamide; Rabbits; Rats; Shock | 1980 |
Pharmacological effects of nicotinamide. Probable endogenous ligand of benzodiazepine receptors.
Topics: Animals; Benzodiazepines; Inosine; Male; Mice; Nervous System; Niacinamide; Rats; Receptors, Cell Surface; Receptors, GABA-A | 1982 |
Extracellular inosine is modulated by H2O2 and protects sertoli cells against lipoperoxidation and cellular injury.
Topics: Adenine; Adenosine Deaminase Inhibitors; Adenosine Triphosphate; Animals; Cell Survival; Cells, Cultured; Dipyridamole; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrogen Peroxide; Inosine; Lipid Peroxidation; Male; Niacinamide; Oxidants; Oxidative Stress; Rats; Sertoli Cells; Thioinosine | 2004 |
Transformation products of extracellular NAD(+) in the rat liver: kinetics of formation and metabolic action.
Topics: Adenosine Diphosphate Ribose; Animals; Glucose; Infusion Pumps; Inosine; Liver; Male; NAD; Niacinamide; Pyruvic Acid; Rats; Rats, Wistar; Time Factors; Uric Acid | 2008 |
Transformation and action of extracellular NAD+ in perfused rat and mouse livers.
Topics: Adenosine Diphosphate Ribose; Adenosine Monophosphate; Animals; Chromatography, High Pressure Liquid; Gluconeogenesis; Inosine; Liver; Male; Mice; NAD; Niacinamide; Oxygen Consumption; Perfusion; Rats; Rats, Sprague-Dawley; Rats, Wistar; Uric Acid | 2009 |
Inosine mitigated diabetic peripheral neuropathy via modulating GLO1/AGEs/RAGE/NF-κB/Nrf2 and TGF-β/PKC/TRPV1 signaling pathways.
Topics: Animals; Caffeine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hyperglycemia; Hypoglycemic Agents; Inosine; Male; Neuroprotective Agents; Niacinamide; Oxidative Stress; Rats; Rats, Wistar; Receptors, Purinergic P1; Signal Transduction; Streptozocin | 2022 |
Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.
Topics: Clinical Studies as Topic; Humans; Inosine; Interferon-beta; Lipopolysaccharides; Lupus Erythematosus, Systemic; Monocytes; NAD; Niacinamide; Toll-Like Receptor 4 | 2022 |